MedPath

Goal Directed Fluid Therapy in Free Flap Reconstructive Surgery

Not Applicable
Completed
Conditions
Head and Neck Cancer
Interventions
Other: Goal directed fluid management based on continuous monitoring of stroke volume
Registration Number
NCT01129037
Lead Sponsor
University Health Network, Toronto
Brief Summary

Wide excision of head and neck cancer with microsurgical free flap's reconstruction (FFR) results to a high cancer cure rate and a good functional recovery. However, this long complex procedure is accompanied with considerable complications. Excessive fluid administration during this type of surgery has been connected with poor results. There is growing evidence that goal-directed fluid management (GDFM) might improve the results in high-risk patients.

Hypothesis: Goal directed fluid management will reduce intraoperative fluid volume administered to patients undergoing head and neck reconstructive surgery.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
78
Inclusion Criteria
  • Age 18-80 years
  • Signed informed consent
Read More
Exclusion Criteria
  • History CHF
  • Severe valvular heart defects, intra cardiac shunts
  • Irregular heart rhythm
  • Allergy to hydroxyethyl starch solutions
  • Coagulation abnormalities (INR>1.5, aPTT>40s, platelet count<100x10 9/L
  • History of severe bleeding disorders
  • Renal insufficiency with creatinine >200Umol/L
  • Pregnant of nursing women
  • History of skin disorders that are accompanied by chronic puritis
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Goal directed fluid managementGoal directed fluid management based on continuous monitoring of stroke volume-
Primary Outcome Measures
NameTimeMethod
The volume of fluid administered intraoperatively during reconstructive surgery for head and neck oncologyInitiation of surgery to end of surgery on average 8-10 hours
Secondary Outcome Measures
NameTimeMethod
Incidence of major complication and LOSPost operative day 0 to hospital discharge

Cardiovascular, respiratory, neurologic, thromboembolic, renal,liver, GI, sepsis,and surgical complications willl be recorded

Trial Locations

Locations (1)

Toronto General Hospital, UHN

🇨🇦

Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath